Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
12th Man Technologies is a medical device company specializing in the development of advanced respiratory and critical care solutions. The company focuses on high-flow oxygen therapy and innovative ventilation technologies designed to improve patient outcomes while reducing the complexity of care in both hospital and home settings. Their product portfolio includes systems for high-flow nasal cannula therapy and portable oxygen delivery, specifically targeting conditions such as respiratory failure and chronic obstructive pulmonary disease. During the COVID-19 pandemic, the company gained recognition for its rapid development of scalable respiratory support systems. Based in California, 12th Man Technologies leverages engineering expertise to bridge the gap between hospital-grade performance and user-friendly design.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 12th Man Technologies.